{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:48:57Z","timestamp":1790668137112,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T00:00:00Z","timestamp":1628726400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T00:00:00Z","timestamp":1628726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100007560","name":"Chiesi Farmaceutici","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007560","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s11239-021-02539-8","type":"journal-article","created":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T16:03:02Z","timestamp":1628784182000},"page":"380-389","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Perioperative risk and antiplatelet management in patients undergoing non-cardiac surgery within 1 year of PCI"],"prefix":"10.1007","volume":"53","author":[{"given":"Davide","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew A.","family":"Levin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Sartori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bimmer","family":"Claessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasios","family":"Roumeliotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongjie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johny","family":"Nicolas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishi","family":"Chandiramani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashi","family":"Bedekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaha","family":"Waseem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ridhima","family":"Goel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Chiarito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonnie","family":"Lupo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Jhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George D.","family":"Dangas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usman","family":"Baber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak L.","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samin K.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annapoorna S.","family":"Kini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxana","family":"Mehran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,12]]},"reference":[{"issue":"20","key":"2539_CR1","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1016\/j.jacc.2012.08.966","volume":"60","author":"GJ Dehmer","year":"2012","unstructured":"Dehmer GJ, Weaver D, Roe MT, Milford-Beland S, Fitzgerald S, Hermann A et al (2012) A contemporary view of diagnostic cardiac catheterization and percutaneous coronary intervention in the United States: a report from the CathPCI registry of the national cardiovascular data registry, 2010 through June 2011. J Am Coll Cardiol 60(20):2017\u20132031","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl 2","key":"2539_CR2","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1016\/S2214-109X(15)70087-2","volume":"3","author":"J Rose","year":"2015","unstructured":"Rose J, Weiser TG, Hider P, Wilson L, Gruen RL, Bickler SW (2015) Estimated need for surgery worldwide based on prevalence of diseases: a modelling strategy for the WHO global health estimate. Lancet Glob Health 3(Suppl 2):S13\u2013S20","journal-title":"Lancet Glob Health"},{"key":"2539_CR3","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ahj.2019.07.010","volume":"217","author":"NR Smilowitz","year":"2019","unstructured":"Smilowitz NR, Lorin J, Berger JS (2019) Risks of noncardiac surgery early after percutaneous coronary intervention. Am Heart J 217:64\u201371","journal-title":"Am Heart J"},{"issue":"4","key":"2539_CR4","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.jamcollsurg.2011.12.011","volume":"214","author":"MT Hawn","year":"2012","unstructured":"Hawn MT, Graham LA, Richman JR, Itani KM, Plomondon ME, Altom LK et al (2012) The incidence and timing of noncardiac surgery after cardiac stent implantation. J Am Coll Surg 214(4):658\u2013666","journal-title":"J Am Coll Surg"},{"issue":"1","key":"2539_CR5","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41569-020-0410-z","volume":"18","author":"D Cao","year":"2021","unstructured":"Cao D, Chandiramani R, Capodanno D, Berger JS, Levin MA, Hawn MT et al (2021 Jan) Non-cardiac surgery in patients with coronary artery disease: risk evaluation and periprocedural management. Nat Rev Cardiol 18(1):37\u201357","journal-title":"Nat Rev Cardiol"},{"issue":"3","key":"2539_CR6","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/eurheartj\/ehx419","volume":"39","author":"M Valgimigli","year":"2018","unstructured":"Valgimigli M, Bueno H, Byrne RA, Collet JP, Costa F, Jeppsson A et al (2018) 2017 ESCfocused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: the task force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 39(3):213\u2013260","journal-title":"Eur Heart J"},{"issue":"10","key":"2539_CR7","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/j.jacc.2016.03.513","volume":"68","author":"GN Levine","year":"2016","unstructured":"Levine GN, Bates ER, Bittl JA, Brindis RG, Fihn SD, Fleisher LA et al (2016) 2016 ACC\/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 68(10):1082\u20131150","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"2539_CR8","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1503\/cmaj.050011","volume":"173","author":"PJ Devereaux","year":"2005","unstructured":"Devereaux PJ, Goldman L, Cook DJ, Gilbert K, Leslie K, Guyatt GH (2005) Perioperative cardiac events in patients undergoing noncardiac surgery: a review of the magnitude of the problem, the pathophysiology of the events and methods to estimate and communicate risk. CMAJ 173(6):627\u2013634","journal-title":"CMAJ"},{"issue":"17","key":"2539_CR9","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1001\/jama.293.17.2126","volume":"293","author":"I Iakovou","year":"2005","unstructured":"Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G et al (2005) Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293(17):2126\u20132130","journal-title":"JAMA"},{"issue":"16","key":"2539_CR10","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/j.jacc.2008.12.055","volume":"53","author":"JW van Werkum","year":"2009","unstructured":"van Werkum JW, Heestermans AA, Zomer AC, Kelder JC, Suttorp MJ, Rensing BJ et al (2009) Predictors of coronary stent thrombosis: the Dutch stent thrombosis registry. J Am Coll Cardiol 53(16):1399\u20131409","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"2539_CR11","doi-asserted-by":"publisher","first-page":"237","DOI":"10.7326\/M17-2341","volume":"168","author":"MM Graham","year":"2018","unstructured":"Graham MM, Sessler DI, Parlow JL, Biccard BM, Guyatt G, Leslie K et al (2018) Aspirin in patients with previous percutaneous coronary intervention undergoing noncardiac surgery. Ann Intern Med 168(4):237\u2013244","journal-title":"Ann Intern Med"},{"issue":"1","key":"2539_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/SLA.0000000000002279","volume":"267","author":"JA Columbo","year":"2018","unstructured":"Columbo JA, Lambour AJ, Sundling RA, Chauhan NB, Bessen SY, Linshaw DL et al (2018) A meta-analysis of the impact of aspirin, clopidogrel, and dual antiplatelet therapy on bleeding complications in noncardiac surgery. Ann Surg 267(1):1\u201310","journal-title":"Ann Surg"},{"issue":"2","key":"2539_CR13","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.bja.2018.09.029","volume":"122","author":"S Howell","year":"2019","unstructured":"Howell S, Hoeks S, West R, Wheatcroft S, Hoeft A, Leva B et al (2019) Prospective observational cohort study of the association between antiplatelet therapy, bleeding and thrombosis in patients with coronary stents undergoing noncardiac surgery. Br J Anaesth 122(2):170\u2013179","journal-title":"Br J Anaesth"},{"issue":"3","key":"2539_CR14","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1097\/00000542-194105000-00004","volume":"2","author":"MMD Saklad","year":"1941","unstructured":"Saklad MMD (1941) Grading of patients for surgical procedures. Anesthesiology 2(3):281\u2013284","journal-title":"Anesthesiology"},{"issue":"35","key":"2539_CR15","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1093\/eurheartj\/ehu285","volume":"35","author":"SD Kristensen","year":"2014","unstructured":"Kristensen SD, Knuuti J, Saraste A, Anker S, Botker HE, De Hert S et al (2014) 2014 ESC\/ESA guidelines on non-cardiac surgery: cardiovascular assessment and management the joint task force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur Heart J 35(35):2383\u20132431","journal-title":"Eur Heart J"},{"issue":"9906","key":"2539_CR16","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1016\/S0140-6736(13)61720-1","volume":"382","author":"R Mehran","year":"2013","unstructured":"Mehran R, Baber U, Steg PG, Ariti C, Weisz G, Witzenbichler B et al (2013) Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study. Lancet 382(9906):1714\u20131722","journal-title":"Lancet"},{"issue":"16","key":"2539_CR17","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1161\/CIR.0b013e31826e1058","volume":"126","author":"K Thygesen","year":"2012","unstructured":"Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD et al (2012) Third universal definition of myocardial infarction. Circulation 126(16):2020\u20132035","journal-title":"Circulation"},{"issue":"1","key":"2539_CR18","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1001\/archsurg.2011.790","volume":"147","author":"VA Ferraris","year":"2012","unstructured":"Ferraris VA, Davenport DL, Saha SP, Austin PC, Zwischenberger JB (2012) Surgical outcomes and transfusion of minimal amounts of blood in the operating room. Arch Surg 147(1):49\u201355","journal-title":"Arch Surg"},{"issue":"21","key":"2539_CR19","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1056\/NEJMoa1503943","volume":"373","author":"P Urban","year":"2015","unstructured":"Urban P, Meredith IT, Abizaid A, Pocock SJ, Carrie D, Naber C et al (2015) Polymer-free drug-coated coronary stents in patients at high bleeding risk. N Engl J Med 373(21):2038\u20132047","journal-title":"N Engl J Med"},{"issue":"13","key":"2539_CR20","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1056\/NEJMoa1910021","volume":"382","author":"S Windecker","year":"2020","unstructured":"Windecker S, Latib A, Kedhi E, Kirtane AJ, Kandzari DE, Mehran R et al (2020) Polymer-based or polymer-free stents in patients at high bleeding risk. N Engl J Med 382(13):1208\u20131218","journal-title":"N Engl J Med"},{"issue":"2","key":"2539_CR21","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/S0735-1097(03)00622-3","volume":"42","author":"SH Wilson","year":"2003","unstructured":"Wilson SH, Fasseas P, Orford JL, Lennon RJ, Horlocker T, Charnoff NE et al (2003) Clinical outcome of patients undergoing non-cardiac surgery in the two months following coronary stenting. J Am Coll Cardiol 42(2):234\u2013240","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"2539_CR22","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.jcin.2009.03.014","volume":"2","author":"S Anwaruddin","year":"2009","unstructured":"Anwaruddin S, Askari AT, Saudye H, Batizy L, Houghtaling PL, Alamoudi M et al (2009) Characterization of post-operative risk associated with prior drug-eluting stent use. JACC Cardiovasc Interv 2(6):542\u2013549","journal-title":"JACC Cardiovasc Interv"},{"issue":"1","key":"2539_CR23","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1161\/CIRCOUTCOMES.115.002155","volume":"9","author":"F Saia","year":"2016","unstructured":"Saia F, Belotti LM, Guastaroba P, Berardini A, Rossini R, Musumeci G et al (2016) Risk of adverse cardiac and bleeding events following cardiac and noncardiac surgery in patients with coronary stent: how important is the interplay between stent type and time from stenting to surgery? Circ Cardiovasc Qual Outcomes 9(1):39\u201347","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"24","key":"2539_CR24","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1016\/j.jacc.2016.09.967","volume":"68","author":"G Egholm","year":"2016","unstructured":"Egholm G, Kristensen SD, Thim T, Olesen KK, Madsen M, Jensen SE et al (2016) Risk associated with surgery within 12 months after coronary drug-eluting stent implantation. J Am Coll Cardiol 68(24):2622\u20132632","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"2539_CR25","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.jacc.2015.11.063","volume":"67","author":"KD Mahmoud","year":"2016","unstructured":"Mahmoud KD, Sanon S, Habermann EB, Lennon RJ, Thomsen KM, Wood DL et al (2016) Perioperative cardiovascular risk of prior coronary stent implantation among patients undergoing noncardiac surgery. J Am Coll Cardiol 67(9):1038\u20131049","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"2539_CR26","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.jcin.2017.10.051","volume":"11","author":"R Rossini","year":"2018","unstructured":"Rossini R, Tarantini G, Musumeci G, Masiero G, Barbato E, Calabro P et al (2018) A multidisciplinary approach on the perioperative antithrombotic management of patients with coronary stents undergoing surgery: surgery after stenting 2. JACC Cardiovasc Interv 11(5):417\u2013434","journal-title":"JACC Cardiovasc Interv"},{"issue":"3","key":"2539_CR27","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1001\/jama.2011.2002","volume":"307","author":"DJ Angiolillo","year":"2012","unstructured":"Angiolillo DJ, Firstenberg MS, Price MJ, Tummala PE, Hutyra M, Welsby IJ et al (2012) Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial. JAMA 307(3):265\u2013274","journal-title":"JAMA"},{"issue":"19","key":"2539_CR28","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1056\/NEJMoa1901778","volume":"380","author":"DL Bhatt","year":"2019","unstructured":"Bhatt DL, Pollack CV, Weitz JI, Jennings LK, Xu S, Arnold SE et al (2019) Antibody-based ticagrelor reversal agent in healthy volunteers. N Engl J Med 380(19):1825\u20131833","journal-title":"N Engl J Med"},{"issue":"2","key":"2539_CR29","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jacbts.2017.01.007","volume":"2","author":"GO Angheloiu","year":"2017","unstructured":"Angheloiu GO, Gugiu GB, Ruse C, Pandey R, Dasari RR, Whatling C (2017) Ticagrelor removal from human blood. JACC Basic Transl Sci 2(2):135\u2013145","journal-title":"JACC Basic Transl Sci"},{"issue":"12","key":"2539_CR30","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1016\/j.jacc.2020.06.085","volume":"76","author":"D Capodanno","year":"2020","unstructured":"Capodanno D, Morice MC, Angiolillo DJ, Bhatt DL, Byrne RA, Colleran R et al (2020) Trial design principles for patients at high bleeding risk undergoing PCI: JACC scientific expert panel. J Am Coll Cardiol 76(12):1468\u20131483","journal-title":"J Am Coll Cardiol"},{"issue":"31","key":"2539_CR31","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1093\/eurheartj\/ehz372","volume":"40","author":"P Urban","year":"2019","unstructured":"Urban P, Mehran R, Colleran R, Angiolillo DJ, Byrne RA, Capodanno D et al (2019) Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the academic research consortium for high bleeding risk. Eur Heart J 40(31):2632\u20132653","journal-title":"Eur Heart J"},{"issue":"22","key":"2539_CR32","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.1161\/CIRCULATIONAHA.108.828228","volume":"119","author":"G Landesberg","year":"2009","unstructured":"Landesberg G, Beattie WS, Mosseri M, Jaffe AS, Alpert JS (2009) Perioperative myocardial infarction. Circulation 119(22):2936\u20132944","journal-title":"Circulation"},{"issue":"1","key":"2539_CR33","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1093\/ehjqcco\/qcy032","volume":"5","author":"K Norderud","year":"2019","unstructured":"Norderud K, Egholm G, Thim T, Olesen KKW, Madsen M, Jensen LO et al (2019) Validation of the European Society of Cardiology and European Society of anaesthesiology non-cardiac surgery risk score in patients treated with coronary drug-eluting stent implantation. Eur Heart J Qual Care Clin Outcomes 5(1):22\u201327","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"issue":"14","key":"2539_CR34","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1001\/jama.2013.278787","volume":"310","author":"MT Hawn","year":"2013","unstructured":"Hawn MT, Graham LA, Richman JS, Itani KM, Henderson WG, Maddox TM (2013) Risk of major adverse cardiac events following noncardiac surgery in patients with coronary stents. JAMA 310(14):1462\u20131472","journal-title":"JAMA"},{"issue":"1","key":"2539_CR35","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13643-017-0635-z","volume":"7","author":"CP Childers","year":"2018","unstructured":"Childers CP, Maggard-Gibbons M, Ulloa JG, MacQueen IT, Miake-Lye IM, Shanman R et al (2018) Perioperative management of antiplatelet therapy in patients undergoing non-cardiac surgery following coronary stent placement: a systematic review. Syst Rev 7(1):4","journal-title":"Syst Rev"},{"issue":"11","key":"2539_CR36","doi-asserted-by":"crossref","first-page":"e016218","DOI":"10.1161\/JAHA.119.016218","volume":"9","author":"C Kim","year":"2020","unstructured":"Kim C, Kim JS, Kim H, Ahn SG, Cho S, Lee OH et al (2020) Patterns of antiplatelet therapy during noncardiac surgery in patients with second-generation drug-eluting stents. J Am Heart Assoc 9(11):e016218","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"2539_CR37","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1160\/TH14-05-0436","volume":"113","author":"R Rossini","year":"2015","unstructured":"Rossini R, Musumeci G, Capodanno D, Lettieri C, Limbruno U, Tarantini G et al (2015) Perioperative management of oral antiplatelet therapy and clinical outcomes in coronary stent patients undergoing surgery results of a multicentre registry. Thromb Haemost 113(2):272\u2013282","journal-title":"Thromb Haemost"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-021-02539-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-021-02539-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-021-02539-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T06:48:40Z","timestamp":1673074120000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-021-02539-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,12]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["2539"],"URL":"https:\/\/doi.org\/10.1007\/s11239-021-02539-8","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,12]]},"assertion":[{"value":"19 July 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Dangas reports receiving consulting fees and advisory board fees from AstraZeneca, consulting fees from Biosensors, and previously holding stock in Medtronic. Dr. Baber reports speaker honoraria from AstraZeneca and Boston Scientific. Dr. Bhatt discloses the following relationships - Advisory Board: Cardax, CellProthera, Cereno Scientific, Elsevier Practice Update Cardiology, Janssen, Level Ex, Medscape Cardiology, MyoKardia, Novo Nordisk, PhaseBio, PLx Pharma, Regado Biosciences; Board of Directors: Boston VA Research Institute, Society of Cardiovascular Patient Care, TobeSoft; Chair: American Heart Association Quality Oversight Committee; Data Monitoring Committees: Baim Institute for Clinical Research (formerly Harvard Clinical Research Institute, for the PORTICO trial, funded by St. Jude Medical, now Abbott), Cleveland Clinic (including for the ExCEED trial, funded by Edwards), Contego Medical (Chair, PERFORMANCE 2), Duke Clinical Research Institute, Mayo Clinic, Mount Sinai School of Medicine (for the ENVISAGE trial, funded by Daiichi Sankyo), Population Health Research Institute; Honoraria: American College of Cardiology (Senior Associate Editor, Clinical Trials and News, ACC.org; Vice-Chair, ACC Accreditation Committee), Baim Institute for Clinical Research (formerly Harvard Clinical Research Institute; RE-DUAL PCI clinical trial steering committee funded by Boehringer Ingelheim; AEGIS-II executive committee funded by CSL Behring), Belvoir Publications (Editor in Chief, Harvard Heart Letter), Canadian Medical and Surgical Knowledge Translation Research Group (clinical trial steering committees), Duke Clinical Research Institute (clinical trial steering committees, including for the PRONOUNCE trial, funded by Ferring Pharmaceuticals), HMP Global (Editor in Chief, Journal of Invasive Cardiology), Journal of the American College of Cardiology (Guest Editor; Associate Editor), K2P (Co-Chair, interdisciplinary curriculum), Level Ex, Medtelligence\/ReachMD (CME steering committees), MJH Life Sciences, Population Health Research Institute (for the COMPASS operations committee, publications committee, steering committee, and USA national co-leader, funded by Bayer), Slack Publications (Chief Medical Editor, Cardiology Today\u2019s Intervention), Society of Cardiovascular Patient Care (Secretary\/Treasurer), WebMD (CME steering committees); Other: Clinical Cardiology (Deputy Editor), NCDR-ACTION Registry Steering Committee (Chair), VA CART Research and Publications Committee (Chair); Research Funding: Abbott, Afimmune, Amarin, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Cardax, CellProthera, Cereno Scientific, Chiesi, CSL Behring, Eisai, Ethicon, Ferring Pharmaceuticals, Forest Laboratories, Fractyl, Garmin, HLS Therapeutics, Idorsia, Ironwood, Ischemix, Janssen, Lexicon, Lilly, Medtronic, MyoKardia, Novartis, Novo Nordisk, Owkin, Pfizer, PhaseBio, PLx Pharma, Regeneron, Roche, Sanofi, Synaptic, The Medicines Company, 89Bio; Royalties: Elsevier (Editor, Cardiovascular Intervention: A Companion to Braunwald\u2019s Heart Disease); Site Co-Investigator: Abbott, Biotronik, Boston Scientific, CSI, St. Jude Medical (now Abbott), Svelte; Trustee: American College of Cardiology; Unfunded Research: FlowCo, Merck, Takeda. Dr. Sharma has received from Abbott Vascular, Boston Scientific, and Cardiovascular Systems, Inc. Dr. Mehran reports institutional research grants from Abbott, Abiomed, Applied Therapeutics, Arena, AstraZeneca, Bayer, Biosensors, Boston Scientific, Bristol-Myers Squibb, CardiaWave, CellAegis, CERC, Chiesi, Concept Medical, CSL Behring, DSI, Insel Gruppe AG, Medtronic, Novartis Pharmaceuticals, OrbusNeich, Philips, Transverse Medical, Zoll; personal fees from ACC, Boston Scientific, California Institute for Regenerative Medicine (CIRM), Cine-Med Research, Janssen, WebMD, SCAI; consulting fees paid to the institution from Abbott, Abiomed, AM-Pharma, Alleviant Medical, Bayer, Beth Israel Deaconess, CardiaWave, CeloNova, Chiesi, Concept Medical, DSI, Duke University, Idorsia Pharmaceuticals, Medtronic, Novartis, Philips; Equity\u2009<\u20091\u2009% in Applied Therapeutics, Elixir Medical, STEL, CONTROLRAD (spouse); Scientific Advisory Board for AMA, Biosensors (spouse). All other authors have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The present research was approved by the Institutional Review Board and complied with the principles of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}